scorecardresearch
Monday, July 21, 2025
TopicAPI

Topic: API

‘Lack of therapeutic justification’ — govt bans 14 combination drugs used to treat common ailments

These were a part of 344 fixed dose combinations prohibited for sale by Union Health Ministry in 2016 but the makers of 15 challenged the decision in Delhi High Court.

Inching towards self-reliance: India now makes 35 drug raw materials that were imported before

Chemicals and Fertilisers Minister Mansukh Mandaviya says move will help India become self-reliant in manufacturing key drugs. Most raw materials were so far imported from China.

CSIR working on making 56 bulk drugs in India as Modi govt wants to cut imports from China

China is the biggest supplier of ingredients for drug production in India. Govt has drawn up list of 56 APIs for essential drugs with plans to make them in India.

Drugmakers cry ‘monopoly’ as Modi govt picks 1 firm each to make over 20 key raw materials

PLI scheme is supposed to end India’s dependence on Chinese imports, but drug lobby says firms could end up dependent on one company for a molecule, increasing patients’ bills.

Pharma industry warns of Covid drug shortages as raw materials prices surge 200%

Pharma firms say suspension of cargo from China has resulted hoarding, driving up prices of raw materials, seek govt intervention immediately.

Biden can’t see Indo-Pacific and pandemic with two prisms. Covid is the new reality

One should not be surprised if it turns out that the White House wanted India to agree to some quid-pro-quo for API. The jury is still out on this.

On Camera

What India can learn from Israel about atmanirbharta in defence

India’s fledgling defence industry has struggled to translate capacity into mass production or compete globally, resulting in continued reliance on imports.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.